Lack of effectiveness of tissue plasminogen activator 20 or more days after vitrectomy

Arch Ophthalmol. 1991 May;109(5):614. doi: 10.1001/archopht.1991.01080050020010.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Fibrin / metabolism
  • Humans
  • Middle Aged
  • Postoperative Complications / prevention & control
  • Recurrence
  • Retinal Detachment / surgery*
  • Tissue Plasminogen Activator / administration & dosage*
  • Vitrectomy*

Substances

  • Fibrin
  • Tissue Plasminogen Activator